These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 36609449)
1. Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression. Deng M; Zhang L; Zheng W; Chen J; Du N; Li M; Chen W; Huang Y; Zeng N; Song Y; Chen Y J Exp Clin Cancer Res; 2023 Jan; 42(1):9. PubMed ID: 36609449 [TBL] [Abstract][Full Text] [Related]
2. Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation. Liu H; Xu L; Yue S; Su H; Chen X; Liu Q; Li H; Liang H; Chen X; He J; Ding Z; Zhang B Cancer Commun (Lond); 2024 Sep; 44(9):1018-1041. PubMed ID: 39030964 [TBL] [Abstract][Full Text] [Related]
3. Loss of NAT10 Reduces the Translation of Xu T; Du T; Zhuang X; He X; Yan Y; Wu J; Zhou H; Li Y; Liao X; He J; Liu C; Dong Y; Ou J; Lin S; Chen D; Huang ZP J Am Heart Assoc; 2024 Oct; 13(20):e035714. PubMed ID: 39392166 [TBL] [Abstract][Full Text] [Related]
4. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Wang G; Zhang M; Zhang Y; Xie Y; Zou J; Zhong J; Zheng Z; Zhou X; Zheng Y; Chen B; Liu C Clin Transl Med; 2022 May; 12(5):e738. PubMed ID: 35522942 [TBL] [Abstract][Full Text] [Related]
5. N-acetyltransferase 10 regulates alphavirus replication via N4-acetylcytidine (ac4C) modification of the lymphocyte antigen six family member E (LY6E) mRNA. Dang Y; Li J; Li Y; Wang Y; Zhao Y; Zhao N; Li W; Zhang H; Ye C; Ma H; Zhang L; Liu H; Dong Y; Yao M; Lei Y; Xu Z; Zhang F; Ye W J Virol; 2024 Jan; 98(1):e0135023. PubMed ID: 38169284 [TBL] [Abstract][Full Text] [Related]
6. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Zheng X; Wang Q; Zhou Y; Zhang D; Geng Y; Hu W; Wu C; Shi Y; Jiang J Cancer Commun (Lond); 2022 Dec; 42(12):1347-1366. PubMed ID: 36209353 [TBL] [Abstract][Full Text] [Related]
7. NAT10-mediated RNA acetylation enhances HNRNPUL1 mRNA stability to contribute cervical cancer progression. Long Y; Ren Y; Wei Q; Mobet Y; Liu Y; Zhao H; Liu T; Cheng L; Yi P Int J Med Sci; 2023; 20(8):1079-1090. PubMed ID: 37484809 [TBL] [Abstract][Full Text] [Related]
8. NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression. Zhao CC; Sun X; Chen J; Geng BD Thorac Cancer; 2024 Apr; 15(10):820-829. PubMed ID: 38409918 [TBL] [Abstract][Full Text] [Related]
9. NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation. Shi J; Yang C; Zhang J; Zhao K; Li P; Kong C; Wu X; Sun H; Zheng R; Sun W; Chen L; Kong X Circ Res; 2023 Dec; 133(12):989-1002. PubMed ID: 37955115 [TBL] [Abstract][Full Text] [Related]
10. NAT10 mediated ac4C acetylation driven m Mei Z; Shen Z; Pu J; Liu Q; Liu G; He X; Wang Y; Yue J; Ge S; Li T; Yuan Y; Yang L Cell Commun Signal; 2024 Jan; 22(1):51. PubMed ID: 38233839 [TBL] [Abstract][Full Text] [Related]
11. Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac Jin C; Wang T; Zhang D; Yang P; Zhang C; Peng W; Jin K; Wang L; Zhou J; Peng C; Tan Y; Ji J; Chen Z; Sun Q; Yang S; Tang J; Feng Y; Sun Y J Exp Clin Cancer Res; 2022 Dec; 41(1):345. PubMed ID: 36522719 [TBL] [Abstract][Full Text] [Related]
12. N-acetyltransferase 10 promotes the progression of oral squamous cell carcinoma through N4-acetylcytidine RNA acetylation of MMP1 mRNA. Liu Y; Huang H; Zhang CB; Fan HN Cancer Sci; 2023 Nov; 114(11):4202-4215. PubMed ID: 37705232 [TBL] [Abstract][Full Text] [Related]
13. N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK/mTOR signalling through N4-acetylcytidine modification of SLC30A9. Ding M; Yu Z; Lu T; Hu S; Zhou X; Wang X Clin Transl Med; 2024 Jul; 14(7):e1747. PubMed ID: 38961519 [TBL] [Abstract][Full Text] [Related]
14. NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction. Li G; Ma X; Sui S; Chen Y; Li H; Liu L; Zhang X; Zhang L; Hao Y; Yang Z; Yang S; He X; Wang Q; Tao W; Xu S J Exp Clin Cancer Res; 2024 Oct; 43(1):278. PubMed ID: 39363363 [TBL] [Abstract][Full Text] [Related]
15. NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer. Xie R; Cheng L; Huang M; Huang L; Chen Z; Zhang Q; Li H; Lu J; Wang H; Zhou Q; Huang J; Chen X; Lin T Cancer Res; 2023 May; 83(10):1666-1683. PubMed ID: 36939377 [TBL] [Abstract][Full Text] [Related]
16. The Cytidine N-Acetyltransferase NAT10 Participates in Peripheral Nerve Injury-Induced Neuropathic Pain by Stabilizing SYT9 Expression in Primary Sensory Neurons. Zhang M; Yang K; Wang QH; Xie L; Liu Q; Wei R; Tao Y; Zheng HL; Lin N; Xu H; Yang L; Wang H; Zhang T; Xue Z; Cao JL; Pan Z J Neurosci; 2023 Apr; 43(17):3009-3027. PubMed ID: 36898834 [TBL] [Abstract][Full Text] [Related]
17. NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer. Chen X; Hao Y; Liu Y; Zhong S; You Y; Ao K; Chong T; Luo X; Yin M; Ye M; He H; Lu A; Chen J; Li X; Zhang J; Guo X Adv Sci (Weinh); 2023 Nov; 10(32):e2302705. PubMed ID: 37818745 [TBL] [Abstract][Full Text] [Related]
18. NAT10 promotes the tumorigenesis and progression of laryngeal squamous cell carcinoma through ac4C modification of FOXM1 mRNA. Li Z; Li D; Yang T; Yao C Cancer Biol Ther; 2023 Dec; 24(1):2274143. PubMed ID: 37948132 [TBL] [Abstract][Full Text] [Related]
19. NAT10 and cytidine acetylation in mRNA: intersecting paths in development and disease. Achour C; Oberdoerffer S Curr Opin Genet Dev; 2024 Aug; 87():102207. PubMed ID: 38820741 [TBL] [Abstract][Full Text] [Related]
20. NAT10-mediated AXL mRNA N4-acetylcytidine modification promotes pancreatic carcinoma progression. Zong G; Wang X; Guo X; Zhao Q; Wang C; Shen S; Xiao W; Yang Q; Jiang W; Shen J; Wan R Exp Cell Res; 2023 Jul; 428(2):113620. PubMed ID: 37156457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]